• 1
    Larche, M., Akdis, C. A. and Valenta, R., Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 2006. 6: 761771.
  • 2
    Cottrez, F., Hurst, S. D., Coffman, R. L. and Groux, H., T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 2000. 165: 48484853.
  • 3
    Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., Thunberg, S., Deniz, G. et al., Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 2004. 199: 15671575.
  • 4
    Radulovic, S., Jacobson, M. R., Durham, S. R. and Nouri-Aria, K. T., Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+cells in the nasal mucosa. J. Allergy Clin. Immunol. 2008. 121: 14671472, 1472 e1461.
  • 5
    Akdis, M. and Akdis, C. A., Therapeutic manipulation of immune tolerance in allergic disease. Nat. Rev. Drug Discov. 2009. 8: 645660.
  • 6
    Akdis, C. A., Blesken, T., Akdis, M., Wuthrich, B. and Blaser, K., Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 1998. 102: 98106.
  • 7
    Meiler, F., Zumkehr, J., Klunker, S., Ruckert, B., Akdis, C. A. and Akdis, M., In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 2008. 205: 28872898.
  • 8
    Jutel, M., Akdis, M., Budak, F., Aebischer-Casaulta, C., Wrzyszcz, M., Blaser, K. and Akdis, C. A., IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 2003. 33: 12051214.
  • 9
    Akdis, C. A. and Akdis, M., Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J. Allergy Clin. Immunol. 2009. 123: 735746; quiz 747–738.
  • 10
    Dillon, S. R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S. R., Haugen, H. S. et al., Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 2004. 5: 752760.
  • 11
    Kakkar, R. and Lee, R. T., The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat. Rev. Drug Discov. 2008. 7: 827840.
  • 12
    Wang, Y. H., Angkasekwinai, P., Lu, N., Voo, K. S., Arima, K., Hanabuchi, S., Hippe, A. et al., IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J. Exp. Med. 2007. 204: 18371847.
  • 13
    Trautmann, A., Akdis, M., Kleemann, D., Altznauer, F., Simon, H. U., Graeve, T., Noll, M. et al., T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. 2000. 106: 2535.
  • 14
    Basinski, T. M., Holzmann, D., Eiwegger, T., Zimmermann, M., Klunker, S., Meyer, N., Schmid-Grendelmeier, P. et al., Dual nature of T cell-epithelium interaction in chronic rhinosinusitis. J. Allergy Clin. Immunol. 2009. 124: 7480, e71–e78.
  • 15
    Finotto, S., Neurath, M. F., Glickman, J. N., Qin, S., Lehr, H. A., Green, F. H., Ackerman, K. et al., Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002. 295: 336338.
  • 16
    Meyer, N., Zimmermann, M., Bürgler, S., Bassin, C., Woehrl, S., Moritz, K., Rhyner, C. et al., IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J. Allergy Clin. Immunol. 2010. DOI: 10.1016/j.jaci.2010.01.016.
  • 17
    Akkoc, T., de Koning, P. J., Ruckert, B., Barlan, I., Akdis, M. and Akdis, C. A., Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J. Allergy Clin. Immunol. 2008. 121: 652658, e651.
  • 18
    Hellings, P. W., Kasran, A., Liu, Z., Vandekerckhove, P., Wuyts, A., Overbergh, L., Mathieu, C. and Ceuppens, J. L., Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell. Mol. Biol. 2003. 28: 4250.
  • 19
    Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B. et al., Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008. 9: 13411346.
  • 20
    Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M. et al., IL-22-producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J. Allergy Clin. Immunol. 2009. 123: 12441252, e1242.
  • 21
    Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Cianfarani, F. et al., Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 2009. 119: 35733585.
  • 22
    Deniz, G., Erten, G., Kucuksezer, U. C., Kocacik, D., Karagiannidis, C., Aktas, E., Akdis, C. A. and Akdis, M., Regulatory NK cells suppress antigen-specific T cell responses. J. Immunol. 2008. 180: 850857.
  • 23
    Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T. and Sakaguchi, S., CTLA-4 control over Foxp3+regulatory T cell function. Science 2008. 322: 271275.
  • 24
    Gri, G., Piconese, S., Frossi, B., Manfroi, V., Merluzzi, S., Tripodo, C., Viola, A. et al., CD4+CD25+regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008. 29: 771781.
  • 25
    Nonaka, M., Pawankar, R., Fukumoto, A. and Yagi, T., Heterogeneous response of nasal and lung fibroblasts to transforming growth factor-beta 1. Clin. Exp. Allergy 2008. 38: 812821.
  • 26
    Ring, S., Schafer, S. C., Mahnke, K., Lehr, H. A. and Enk, A. H., CD4+CD25+regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur. J. Immunol. 2006. 36: 29812992.
  • 27
    Trautmann, A., Schmid-Grendelmeier, P., Kruger, K., Crameri, R., Akdis, M., Akkaya, A., Brocker, E. B. et al., T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J. Allergy Clin. Immunol. 2002. 109: 329337.
  • 28
    Meiler, F., Klunker, S., Zimmermann, M., Akdis, C. A. and Akdis, M., Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 2008. 63: 14551463.
  • 29
    Jaffar, Z., Ferrini, M. E., Girtsman, T. A. and Roberts, K., Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. Eur. J. Immunol. 2009. 39: 33073314.
  • 30
    Sakaguchi, S., Wing, K. and Yamaguchi, T., Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur. J. Immunol. 2009. 39: 23312336.
  • 31
    Bach, J. F., The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 2002. 347: 911920.
  • 32
    Linehan, M. F., Frank, T. L., Hazell, M. L., Francis, H. C., Morris, J. A., Baxter, D. N. and Niven, R. M., Is the prevalence of wheeze in children altered by neonatal BCG vaccination? J. Allergy Clin. Immunol. 2007. 119: 10791085.
  • 33
    Romagnani, S., Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J. Allergy Clin. Immunol. 2007. 119: 15111513.
  • 34
    Koski, G. K., Kariko, K., Xu, S., Weissman, D., Cohen, P. A. and Czerniecki, B. J., Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J. Immunol. 2004. 172: 39893993.
  • 35
    Parronchi, P., Brugnolo, F., Annunziato, F., Manuelli, C., Sampognaro, S., Mavilia, C., Romagnani, S. and Maggi, E., Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+T cells into Th1 effectors. J. Immunol. 1999. 163: 59465953.
  • 36
    Santeliz, J. V., Van Nest, G., Traquina, P., Larsen, E. and Wills-Karp, M., Amb a 1-linked CpG oliginucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J. Allergy Clin. Immunol. 2002. 109.
  • 37
    Debarry, J., Garn, H., Hanuszkiewicz, A., Dickgreber, N., Blumer, N., von Mutius, E., Bufe, A. et al., Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J. Allergy Clin, Immunol. 2007. 119: 15141521.
  • 38
    Turcanu, V., Maleki, S. J. and Lack, G., Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J. Clin. Invest. 2003. 111: 10651072.
  • 39
    Marshall, J. D., Abtahi, S., Eiden, J. J., Tuck, S., Milley, R., Haycock, F., Reid, M. J. et al., Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J. Allergy Clin. Immunol. 2001. 108: 191197.
  • 40
    Tulic, M. K., Fiset, P. O., Christodoulopoulos, P., Vaillancourt, P., Desrosiers, M., Lavigne, F., Eiden, J. and Hamid, Q., Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J. Allergy Clin. Immunol. 2004. 113: 235241.
  • 41
    Liotta, F., Frosali, F., Querci, V., Mantei, A., Fili, L., Maggi, L., Mazzinghi, B. et al., Human immature myeloid dendritic cells trigger a TH2-polarizing program via Jagged-1/Notch interaction. J. Allergy Clin. Immunol. 2008. 121: 10001005 e1008.
  • 42
    Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003. 4: 330336.
  • 43
    Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C. and Bowcock, A. M., JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest 2000. 106: R75R81.
  • 44
    Bottema, R. W., Kerkhof, M., Reijmerink, N. E., Koppelman, G. H., Thijs, C., Stelma, F. F., Smit, H. A. et al., X-chromosome Forkhead Box P3 polymorphisms associate with atopy in girls in three Dutch birth cohorts. Allergy 2009. DOI: 10.1111/j.1398-99995.2009.02291.
  • 45
    Lin, W., Truong, N., Grossman, W. J., Haribhai, D., Williams, C. B., Wang, J., Martin, M. G. and Chatila, T. A., Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J. Allergy Clin. Immunol. 2005. 116: 11061115.
  • 46
    Ono, M., Yaguchi, H., Ohkura, N., Kitabayashi, I., Nagamura, Y., Nomura, T., Miyachi, Y. et al., Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007. 446: 685689.
  • 47
    Rudra, D., Egawa, T., Chong, M. M., Treuting, P., Littman, D. R. and Rudensky, A. Y., Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 2009. 10: 11701177.
  • 48
    Klunker, S., Chong, M. M., Mantel, P. Y., Palomares, O., Bassin, C., Ziegler, M., Ruckert, B. et al., Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+inducible regulatory T cells. J. Exp. Med. 2009. 206: 27012715.
  • 49
    Probst-Kepper, M., Geffers, R., Kroger, A., Viegas, N., Erck, C., Hecht, H. J., Lunsdorf, H. et al., GARP: a key receptor controlling FOXP3 in human regulatory T cells. J. Cell Mol. Med. 2009. 13: 33433357.
  • 50
    Wang, R., Kozhaya, L., Mercer, F., Khaitan, A., Fujii, H. and Unutmaz, D., Expression of GARP selectively identifies activated human FOXP3+regulatory T cells. Proc. Natl. Acad. Sci. USA 2009. 106: 1343913444.
  • 51
    Valmori, D., Merlo, A., Souleimanian, N. E., Hesdorffer, C. S. and Ayyoub, M., A peripheral circulating compartment of natural naïve CD4 Tregs. J. Clin. Invest. 2005. 115: 19531962.
  • 52
    Ito, T., Hanabuchi, S., Wang, Y. H., Park, W. R., Arima, K., Bover, L., Qin, F. X. et al., Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008. 28: 870880.
  • 53
    Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M. et al., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006. 203: 16931700.
  • 54
    Coombes, J. L., Siddiqui, K. R., Arancibia-Carcamo, C. V., Hall, J., Sun, C. M., Belkaid, Y. and Powrie, F., A functionally specialized population of mucosal CD103+DCs induces Foxp3+regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007. 204: 17571764.
  • 55
    Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. and Enk, A. H., Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000. 192: 12131222.
  • 56
    Rissoan, M. C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R. and Liu, Y. J., Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999. 283: 11831186.
  • 57
    Vermaelen, K. Y., Carro-Muino, I., Lambrecht, B. N. and Pauwels, R. A., Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 2001. 193: 5160.
  • 58
    Akbari, O., DeKruyff, R. H. and Umetsu, D. T., Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001. 2: 725731.
  • 59
    Ito, T., Yang, M., Wang, Y. H., Lande, R., Gregorio, J., Perng, O. A., Qin, X. F. et al., Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 2007. 204: 105115.
  • 60
    Chen, W., Liang, X., Peterson, A. J., Munn, D. H. and Blazar, B. R., The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 2008. 181: 53965404.
  • 61
    de Heer, H. J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M. A., Hoogsteden, H. C. and Lambrecht, B. N., Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 2004. 200: 8998.
  • 62
    Darrasse-Jeze, G., Deroubaix, S., Mouquet, H., Victora, G. D., Eisenreich, T., Yao, K. H., Masilamani, R. F. et al., Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 2009. 206: 18531862.
  • 63
    McGuirk, P., McCann, C. and Mills, K. H., Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 2002. 195: 221231.
  • 64
    Csoka, B., Himer, L., Selmeczy, Z., Vizi, E. S., Pacher, P., Ledent, C., Deitch, E. A. et al., Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J. 2008. 22: 34913499.
  • 65
    Urry, Z., Xystrakis, E., Richards, D. F., McDonald, J., Sattar, Z., Cousins, D. J., Corrigan, C. J. et al., Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. J. Clin. Invest. 2009. 119: 387398.
  • 66
    Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M. and Cheroutre, H., Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007. 317: 256260.
  • 67
    Mantel, P. Y., Kuipers, H., Boyman, O., Rhyner, C., Ouaked, N., Ruckert, B., Karagiannidis, C. et al., GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 2007. 5: e329.
  • 68
    Zhang, L. and Zhao, Y., The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road. J. Cell Physiol. 2007. 211: 590597.
  • 69
    Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231234.
  • 70
    Elias, K. M., Laurence, A., Davidson, T. S., Stephens, G., Kanno, Y., Shevach, E. M. and O'Shea, J. J., Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 2008. 111: 10131020.
  • 71
    Platts-Mills, T., Vaughan, J., Squillace, S., Woodfolk, J. and Sporik, R., Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001. 357: 752756.
  • 72
    Verhasselt, V., Milcent, V., Cazareth, J., Kanda, A., Fleury, S., Dombrowicz, D., Glaichenhaus, N. and Julia, V., Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat. Med. 2008. 14: 170175.
  • 73
    Karlsson, M. R., Rugtveit, J. and Brandtzaeg, P., Allergen-responsive CD4+CD25+regulatory T cells in children who have outgrown cow's milk allergy. J. Exp. Med. 2004. 199: 16791688.
  • 74
    Nouri-Aria, K. T., Wachholz, P. A., Francis, J. N., Jacobson, M. R., Walker, S. M., Wilcock, L. K., Staple, S. Q. et al., Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J. Immunol. 2004. 172: 32523259.
  • 75
    Bohle, B., Kinaciyan, T., Gerstmayr, M., Radakovics, A., Jahn-Schmid, B. and Ebner, C., Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J. Allergy Clin. Immunol. 2007. 120: 707713.
  • 76
    Ling, E. M., Smith, T., Nguyen, X. D., Pridgeon, C., Dallman, M., Arbery, J., Carr, V. A. and Robinson, D. S., Relation of CD4+CD25+regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004. 363: 608615.
  • 77
    Burastero, S. E., Mistrello, G., Falagiani, P., Paolucci, C., Breda, D., Roncarolo, D., Zanotta, S. et al., Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production. Ann. Allergy Asthma Immunol. 2008. 100: 343350.
  • 78
    Passalacqua, G., Albano, M., Riccio, A., Fregonese, L., Puccinelli, P., Parmiani, S. and Canonica, G. W., Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 1999. 104: 964968.
  • 79
    Moingeon, P., Batard, T., Fadel, R., Frati, F., Sieber, J. and Van Overtvelt, L., Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006. 61: 151165.
  • 80
    Muller, U., Akdis, C. A., Fricker, M., Akdis, M., Blesken, T., Bettens, F. and Blaser, K., Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J. Allergy Clin. Immunol. 1998. 101: 747754.
  • 81
    Oldfield, W. L., Larche, M. and Kay, A. B., Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002. 360: 4753.
  • 82
    Campbell, J. D., Buckland, K. F., McMillan, S. J., Kearley, J., Oldfield, W. L., Stern, L. J., Gronlund, H. et al., Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J. Exp. Med. 2009. 206: 15351547.